Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Non-cash Items (2016 - 2024)

PAVmed has reported Non-cash Items over the past 5 years, most recently at $191000.0 for Q3 2024.

  • For Q3 2024, Non-cash Items changed N/A year-over-year to $191000.0; the TTM value through Sep 2024 reached $191000.0, changed N/A, while the annual FY2023 figure was $6666.0, 98.44% down from the prior year.
  • Non-cash Items for Q3 2024 was $191000.0 at PAVmed, down from $199000.0 in the prior quarter.
  • Over five years, Non-cash Items peaked at $45.3 million in Q3 2021 and troughed at $7000.0 in Q2 2023.
  • A 5-year average of $6.2 million and a median of $433500.0 in 2022 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: tumbled 99.97% in 2022 and later surged 2742.86% in 2024.
  • Year by year, Non-cash Items stood at $2.6 million in 2020, then soared by 37.45% to $3.5 million in 2021, then plummeted by 87.83% to $428000.0 in 2022, then decreased by 20.33% to $341000.0 in 2023, then crashed by 43.99% to $191000.0 in 2024.
  • Business Quant data shows Non-cash Items for PAVM at $191000.0 in Q3 2024, $199000.0 in Q2 2024, and $195000.0 in Q1 2024.